Leyre Lloreda-Martin1; Ana Berrocal-Cuadrado2; Maria Angeles Torres Nieto3; Alicia Galindo-Ferreiro2
DOI: 10.5935/0004-2749.2022-0091
ABSTRACT
Hepatitis C virus infection may be implicated in 12.7% of ocular adnexal marginal zone lymphomas. We present the first case of an orbital-systemic mucosa-associated lymphoid tissue lymphoma that responded to hepatitis C virus medical treatment. A 62-year-old male with a right-sided orbital mass was diagnosed with stage IIA orbital marginal zone lymphoma in addition to hepatitis C virus infection based on clinical, imaging, laboratory, and histological examinations. The systemic and orbital responses were achieved 1 year after undergoing hepatitis C virus treatment with glecaprevir/pibrentasvir. The association between the hepatitis C virus infection and orbital-systemic mucosa-associated lymphoid tissue lymphoma is relevant. Accordingly, patients with orbital mucosa-associated lymphoid tissue lymphoma should be assessed for hepatitis C virus seroreactivity for therapeutic and prognostic purposes.
Keywords: Orbital disease; Orbital neoplasms; Lymphoma, B-cell marginal zone; Hepacivirus; Hepatitis C; Humans; Case reports
© 2024 - All rights reserved - Conselho Brasileiro de Oftalmologia
Read in English
English PDF
Print
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter
Share on Linkedin
Share on WhatsApp
